We will answer any question specifically for you for only $13.00 $11/page
Pagana: Mosby’s Manual of Diagnostic and Laboratory Tests, 6th Edition
The patient, a 16-year-old high-school football player, was brought to the emergency room in a coma. His mother said that during the past month, he had lost 12 pounds and experienced excessive thirst associated with voluminous urination that often required voiding several times during the night. There was a strong family history of diabetes mellitus (DM). The physical examination results were essentially negative except for sinus tachycardia and Kussmaul respirations.
Studies | Results |
Serum glucose test (on admission), p. 227 | 1100 mg/dL (normal: 60–120 mg/dL) |
Arterial blood gases (ABGs) test (on admission), p. 98 | |
pH | 7.23 (normal: 7.35–7.45) |
PCO2 | 30 mm Hg (normal: 35–45 mm Hg) |
HCO2 | 12 mEq/L (normal: 22–26 mEq/L) |
Serum osmolality test, p. 339 | 440 mOsm/kg (normal: 275–300 mOsm/kg) |
Serum glucose test, p. 227 | 250 mg/dL (normal: 70–115 mg/dL) |
2-hour postprandial glucose test (2-hour PPG), p. 230 | 500 mg/dL (normal: <140 mg/dL) |
Glucose tolerance test (GTT), p. 234 | |
Fasting blood glucose | 150 mg/dL (normal: 70–115 mg/dL) |
30 minutes | 300 mg/dL (normal: <200 mg/dL) |
1 hour | 325 mg/dL (normal: <200 mg/dL) |
2 hours | 390 mg/dL (normal: <140 mg/dL) |
3 hours | 300 mg/dL (normal: 70–115 mg/dL) |
4 hours | 260 mg/dL (normal: 70–115 mg/dL) |
Glycosylated hemoglobin, p. 238 | 9% (normal: <7%) |
Diabetes mellitus autoantibody panel, p. 186 | |
insulin autoantibody | Positive titer >1/80 |
islet cell antibody | Positive titer >1/120 |
glutamic acid decarboxylase antibody | Positive titer >1/60 |
Microalbumin, p. 872 | <20 mg/L |
The patient’s symptoms and diagnostic studies were classic for hyperglycemic ketoacidosis associated with DM. The glycosylated hemoglobin showed he had been hyperglycemic over the last several months. The results of his arterial blood gases (ABGs) test on admission indicated metabolic acidosis with some respiratory compensation. He was treated in the
Case Studies 2
emergency room with IV regular insulin and IV fluids; however, before he received any insulin levels, insulin antibodies were obtained and were positive, indicating a degree of insulin resistance. His microalbumin was normal, showing no evidence of diabetic renal disease, often a late complication of diabetes.
During the first 72 hours of hospitalization, the patient was monitored with frequent serum glucose determinations. Insulin was administered according to the results of these studies. His condition was eventually stabilized on 40 units of Humulin N insulin daily. He was converted to an insulin pump and did very well with that. Comprehensive patient instruction regarding self-blood glucose monitoring, insulin administration, diet, exercise, foot care, and recognition of the signs and symptoms of hyperglycemia and hypoglycemia was given.
1. Why was this patient in metabolic acidosis?
The patient was in metabolic acidosis due to diabetic ketoacidosis (DKA). DKA is a severe complication of diabetes mellitus, typically type 1 diabetes, where the body lacks sufficient insulin to utilize glucose for energy. Consequently, the body starts breaking down fat for fuel, producing ketones as a byproduct. These ketones accumulate in the bloodstream, leading to metabolic acidosis. The key indicators of metabolic acidosis in this patient include:
2. Do you think the patient will be switched eventually to an oral hypoglycemic agent?
It is unlikely that the patient will be switched to an oral hypoglycemic agent. The patient’s positive diabetes mellitus autoantibody panel (insulin autoantibody, islet cell antibody, and glutamic acid decarboxylase antibody) strongly suggests type 1 diabetes mellitus. Type 1 diabetes is characterized by autoimmune destruction of pancreatic beta cells, resulting in an absolute deficiency of insulin. Unlike type 2 diabetes, which can often be managed with oral hypoglycemic agents that enhance insulin sensitivity or secretion, type 1 diabetes requires exogenous insulin for glucose regulation. Therefore, the patient will likely need to continue insulin therapy, possibly with adjustments in the form of an insulin pump or multiple daily injections.
3. How do you anticipate this adolescent's social life is going to be affected?
The adolescent’s social life is likely to be affected in several ways:
4. How could you help this patient to be compliant with his treatment?
To help this patient be compliant with his treatment, several strategies can be employed:
These strategies can help the patient integrate diabetes management into his daily routine more seamlessly and improve his overall adherence to the treatment plan.
Powered by Writersearch.com - academic service with a 3-hour delivery